Old Republic International (ORI)’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-361,000
Closed -$28.6M 94
2018
Q3
$28.6M Hold
361,000
0.83% 48
2018
Q2
$25.3M Sell
361,000
-265,500
-42% -$19.1M 0.78% 55
2018
Q1
$43.8M Hold
626,500
1.4% 21
2017
Q4
$43.5M Buy
626,500
+151,000
+32% +$10.2M 1.38% 25
2017
Q3
$32.2M Hold
475,500
1.07% 36
2017
Q2
$32.4M Hold
475,500
1.06% 37
2017
Q1
$29.6M Hold
475,500
1.02% 41
2016
Q4
$26M Buy
475,500
+92,500
+24% +$5.25M 0.93% 48
2016
Q3
$24.6M Buy
+383,000
New +$25M 1.07% 37

Other funds holding AZN

Old Republic International (ORI)'s AZN Position: Q4 2018 in Review

Old Republic International (ORI) sold out of AstraZeneca (AZN) in Q4 2018, closing a stake of 361,000 shares — an estimated $28.6M sold.

Old Republic International (ORI) first reported a position in AZN in Q3 2016 and held it in 9 quarters. The position peaked at $43.8M in Q1 2018. 557 funds tracked by Wall St. Rank hold AZN as of Q4 2018.

  • Old Republic International (ORI) reported no remaining AstraZeneca position as of Q4 2018 after selling out during the quarter.
  • Old Republic International (ORI) sold 361,000 AstraZeneca shares in Q4 2018, an estimated $28.6M.
  • Old Republic International (ORI) first reported a position in AstraZeneca in Q3 2016 and held it in 9 quarters.
  • Old Republic International (ORI)'s AstraZeneca position peaked at $43.8M in Q1 2018.
  • 557 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2018.

Based on Old Republic International (ORI)'s 13F filing for Q4 2018, filed 29 Jan 2019.